Key Publications July 11, 2011

Cardiovascular Event Reduction and Adverse Events Among Subjects Attaining Low-Density Lipoprotein Cholesterol <50 mg/dl With Rosuvastatin The JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).

J Am Coll Cardiol 2011;57:1666-75

Hsia J, Macfadyen JG, Monyak J, Ridker PM